Abstral 300 mikrog নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

abstral 300 mikrog

kyowa kirin holdings b.v. - fentanylsitrat - sublingvaltablett - 300 mikrog

Abstral 400 mikrog নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

abstral 400 mikrog

kyowa kirin holdings b.v. - fentanylsitrat - sublingvaltablett - 400 mikrog

Abstral 800 mikrog নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

abstral 800 mikrog

kyowa kirin holdings b.v. - fentanylsitrat - sublingvaltablett - 800 mikrog

Lacosamide UCB ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptics, - lacosamide ucb er indisert som monoterapi og tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.

Valproat Life Medical 100 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

valproat life medical 100 mg/ ml

life medical aps (1) - natriumvalproat - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml

Tivicay ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Erleada ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

erleada

janssen-cilag international nv - apalutamide - prostata neoplasmer - endokrin terapi - erleada er angitt:i voksne menn for behandling av metastatisk ikke kastrering motstandsdyktig mot prostatakreft (nmcrpc) som har høy risiko for å utvikle metastatisk sykdom. i voksne menn for behandling av metastatisk hormone-sensitive prostatakreft (mhspc) i kombinasjon med androgen mangel terapi (adt).